$Avadel Pharmaceuticals (AVDL.US)$just my two bits worth information. if the COO of their primary product is the US, that wikl be good for the stocks value during this presidency…
$Avadel Pharmaceuticals (AVDL.US)$sank more than 25% after hours Wednesday after the biotech reported preliminary Q4 revenues below analyst expectations and released poorly received forward guidance. AVDL fell 25.2% to $8 shortly before 5 p.m. ET after the company announced that Q4 revenues will come in at $50 million – below the $52.7 million that analysts had reportedly expected. The company like...
$Avadel Pharmaceuticals (AVDL.US)$Avadel Pharmaceuticals Presents Results From Social Listening Analysis And Survey Of People With Narcolepsy Uncover Real-Life Challenges With Twice-Nightly Oxybate Therapy; Findings Published In 'Brain Sciences' Showed Missed Doses And Potential For Injury When Waking To Take A Second Dose Among The Key Challenges – Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose among the key challen...
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Avadel Pharmaceuticals Stock Forum
Latest LUMRYZ Data Shows Surging Growth: Avadel Eyes Billion-Dollar Market
LUMRYZ Sales Surge 158% as Avadel Pharmaceuticals Eyes Cash Flow Positive 2025
AVDL fell 25.2% to $8 shortly before 5 p.m. ET after the company announced that Q4 revenues will come in at $50 million – below the $52.7 million that analysts had reportedly expected.
The company like...
yeah, cluster buys drew my attention too
– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose among the key challen...
🎃⚡️🎃
📊⚡️📊
No comment yet